688677 Stock Overview
Engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688677 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Qingdao NovelBeam Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥36.19 |
| 52 Week High | CN¥58.00 |
| 52 Week Low | CN¥25.48 |
| Beta | -0.67 |
| 1 Month Change | -2.32% |
| 3 Month Change | 38.55% |
| 1 Year Change | -32.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -52.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688677 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -4.9% | -3.5% | -2.7% |
| 1Y | -32.3% | -9.6% | 11.8% |
Return vs Industry: 688677 underperformed the CN Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: 688677 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 688677 volatility | |
|---|---|
| 688677 Average Weekly Movement | 8.5% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688677 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688677's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 817 | Yao Zheng | www.novelbeam.com |
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and optical devices and components, including dental endoscopes, light source modules for microscopes and PCR analysis, fluorescence filters, beauty machine filters, light sheets, and high-energy laser scanning mirror, etc. It also provides optical imaging solutions for clinical medicine; and identity information management solutions based on biometrics.
Qingdao NovelBeam Technology Co.,Ltd. Fundamentals Summary
| 688677 fundamental statistics | |
|---|---|
| Market cap | CN¥4.37b |
| Earnings (TTM) | CN¥124.91m |
| Revenue (TTM) | CN¥413.02m |
34.9x
P/E Ratio10.6x
P/S RatioIs 688677 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688677 income statement (TTM) | |
|---|---|
| Revenue | CN¥413.02m |
| Cost of Revenue | CN¥150.98m |
| Gross Profit | CN¥262.04m |
| Other Expenses | CN¥137.13m |
| Earnings | CN¥124.91m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.04 |
| Gross Margin | 63.44% |
| Net Profit Margin | 30.24% |
| Debt/Equity Ratio | 2.5% |
How did 688677 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield53%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 01:40 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Qingdao NovelBeam Technology Co.,Ltd. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Shuo Song | Citic Securities Co., Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |